Retracted: The Clinical Efficacy and Economic Benefits of Recombinant Human Thrombopoietin for the Treatment of Chemotherapy or Chemoradiotherapy-Induced Thrombocytopenia

Detalles Bibliográficos
Autor principal: Imaging, Contrast Media & Molecular
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371756/
https://www.ncbi.nlm.nih.gov/pubmed/37502537
http://dx.doi.org/10.1155/2023/9783232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371756/
https://www.ncbi.nlm.nih.gov/pubmed/37502537
http://dx.doi.org/10.1155/2023/9783232

Ejemplares similares